Investing.com - Bio-Rad Labs B (NYSE: BIOb) reported first quarter EPS of $2.29, $0.12 better than the analyst estimate of $2.17. Revenue for the quarter came in at $610.8M versus the consensus estimate of $616.58M.
Bio-Rad Labs B's stock price closed at $279.05. It is down -13.07% in the last 3 months and down -40.37% in the last 12 months.
Bio-Rad Labs B saw positive EPS revisions and negative EPS revisions in the last 90 days. See Bio-Rad Labs B's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Rad Labs B's Financial Health score is "good performance".
Check out Bio-Rad Labs B's recent earnings performance, and Bio-Rad Labs B's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar